1. Abraham, E., and Shah, S., 1992, Intranasal immunization with liposomes containing IL-2 enhances bacterial Polysaccharide antigen-specific pulmonary secretory antibody response, J. Immunol. 149:3719–3726.
2. Afonso, L. C. C., Scharton, T. M., Viera, L. Q., Wysocka, M., Trinchieri, G., and Scott, P., 1994, The adjuvant effect of interleukin-12 in a vaccine against Leishmania major, Science 263:235–237.
3. Allison, A. C., 1983, Immunological adjuvants and their mode of action, in: New Approaches to Vaccine Development (R. Bell and G. Torrigiani, eds.), WHO, Schwabe & CoAG, Basel, pp. 133–154.
4. Anderson, G., Urbano, O., Fedorka-Cray, P., Newell, A., Nunberg, J., and Doyle, M, 1987, Interleukin-2 and protective immunity in Haemophilus pleuropneumoniae. Preliminary studies, in: Vaccines’ 87, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 22–25.
5. Anderson, K. P., Fennie, E. H., and Yilma, T., 1989, Enhancement of a secondary antibody response to vesicular stomatitis virus “G” protein by IFNg treatment at primary immunization, J. Immunol. 140:3599–3604.